Phenotypic spectrum of glucose transporter type 1 deficiency syndrome (Glut1 DS).

PubWeight™: 1.32‹?› | Rank: Top 10%

🔗 View Article (PMID 23443458)

Published in Curr Neurol Neurosci Rep on April 01, 2013

Authors

Toni S Pearson1, Cigdem Akman, Veronica J Hinton, Kristin Engelstad, Darryl C De Vivo

Author Affiliations

1: Department of Neurology, Columbia University, 710 west 168th Street, New York, NY 10032, USA.

Associated clinical trials:

An Open-Label Trial of Triheptanoin in Patients With Glucose Transporter Type-1 Deficiency Syndrome (GLUT1DS) | NCT02036853

Articles citing this

Crystal structure of the human glucose transporter GLUT1. Nature (2014) 2.12

GLUT1 reductions exacerbate Alzheimer's disease vasculo-neuronal dysfunction and degeneration. Nat Neurosci (2015) 1.07

Pathway-driven discovery of epilepsy genes. Nat Neurosci (2015) 1.00

Cerebral metabolic abnormalities in A3243G mitochondrial DNA mutation carriers. Neurology (2014) 0.94

Association between coenzyme Q10 and glucose transporter (GLUT1) deficiency. BMC Pediatr (2014) 0.88

GLUT, SGLT, and SWEET: Structural and mechanistic investigations of the glucose transporters. Protein Sci (2016) 0.87

GLUT1 deficiency syndrome into adulthood: a follow-up study. J Neurol (2014) 0.87

Genetics of Epilepsy in Clinical Practice. Epilepsy Curr (2015) 0.85

Genetic forms of epilepsies and other paroxysmal disorders. Semin Neurol (2014) 0.84

Ketogenic diet in a patient with congenital hyperinsulinism: a novel approach to prevent brain damage. Orphanet J Rare Dis (2015) 0.75

Brain correlates of spike and wave discharges in GLUT1 deficiency syndrome. Neuroimage Clin (2016) 0.75

Unusual phenotype of glucose transport protein type 1 deficiency syndrome: A case report and literature review. J Pediatr Neurosci (2014) 0.75

Targeted Next Generation Sequencing in Patients with Inborn Errors of Metabolism. PLoS One (2016) 0.75

A Cause of Permanent Ketosis: GLUT-1 Deficiency. JIMD Rep (2014) 0.75

Sugar and Alzheimer's disease: a bittersweet truth. Nat Neurosci (2015) 0.75

Understanding the Spectrum of SLC2A1-Associated Disorders. Pediatr Neurol Briefs (2017) 0.75

Paroxysmal eye-head movements in Glut1 deficiency syndrome. Neurology (2017) 0.75

A novel diagnostic approach to patients with myoclonus. Nat Rev Neurol (2015) 0.75

CoQ10 Deficiency Is Not a Common Finding in GLUT1 Deficiency Syndrome. JIMD Rep (2015) 0.75

Hyperinsulinemic hypoglycemia: clinical, molecular and therapeutical novelties. J Inherit Metab Dis (2017) 0.75

Articles by these authors

An expanded version of the Hammersmith Functional Motor Scale for SMA II and III patients. Neuromuscul Disord (2007) 2.17

Mutational spectrum of DMD mutations in dystrophinopathy patients: application of modern diagnostic techniques to a large cohort. Hum Mutat (2009) 1.88

Glut-1 deficiency syndrome: clinical, genetic, and therapeutic aspects. Ann Neurol (2005) 1.77

Varying loads of the mitochondrial DNA A3243G mutation in different tissues: implications for diagnosis. Am J Med Genet A (2004) 1.64

A mouse model for Glut-1 haploinsufficiency. Hum Mol Genet (2006) 1.63

Delayed developmental language milestones in children with Duchenne's muscular dystrophy. J Pediatr (2007) 1.55

Navajo neurohepatopathy is caused by a mutation in the MPV17 gene. Am J Hum Genet (2006) 1.53

Mitochondrial DNA abnormalities and autistic spectrum disorders. J Pediatr (2004) 1.49

Validation of the Children's Hospital of Philadelphia Infant Test of Neuromuscular Disorders (CHOP INTEND). Pediatr Phys Ther (2011) 1.42

The spectrum of movement disorders in Glut-1 deficiency. Mov Disord (2010) 1.33

Observational study of spinal muscular atrophy type 2 and 3: functional outcomes over 1 year. Arch Neurol (2011) 1.32

Prospective cohort study of spinal muscular atrophy types 2 and 3. Neurology (2012) 1.31

Wolff-Parkinson-White syndrome in Patients With MELAS. Arch Neurol (2007) 1.29

A functionally dominant mitochondrial DNA mutation. Hum Mol Genet (2008) 1.17

Nerve conduction abnormalities in patients with MELAS and the A3243G mutation. Arch Neurol (2006) 1.15

Protean phenotypic features of the A3243G mitochondrial DNA mutation. Arch Neurol (2009) 1.15

Are MRI-detected brain abnormalities associated with febrile seizure type? Epilepsia (2007) 1.14

GLUT1 deficiency and other glucose transporter diseases. Eur J Endocrinol (2004) 1.12

Validation of the Expanded Hammersmith Functional Motor Scale in spinal muscular atrophy type II and III. J Child Neurol (2011) 1.08

Hypocitrullinemia in patients with MELAS: an insight into the "MELAS paradox". J Neurol Sci (2004) 1.07

Association of autistic spectrum disorders with dystrophinopathies. Pediatr Neurol (2009) 1.07

Imaging the metabolic footprint of Glut1 deficiency on the brain. Ann Neurol (2002) 1.06

Clinical spectrum of mitochondrial DNA depletion due to mutations in the thymidine kinase 2 gene. Arch Neurol (2006) 1.05

Mutation screening in patients with isolated cytochrome c oxidase deficiency. Pediatr Res (2003) 1.02

Initiation of breastfeeding among mothers of very low birth weight infants. Pediatrics (2003) 1.02

Structural signatures and membrane helix 4 in GLUT1: inferences from human blood-brain glucose transport mutants. J Biol Chem (2008) 1.01

Increased fat mass and high incidence of overweight despite low body mass index in patients with spinal muscular atrophy. Neuromuscul Disord (2009) 1.01

Seizure characterization and electroencephalographic features in Glut-1 deficiency syndrome. Epilepsia (2003) 0.98

Spontaneous recurrent seizure following status epilepticus enhances dentate gyrus neurogenesis. Brain Dev (2004) 0.97

Neonatal blood carnitine concentrations: normative data by electrospray tandem mass spectometry. Pediatr Res (2003) 0.96

Clinical application of whole-exome sequencing: a novel autosomal recessive spastic ataxia of Charlevoix-Saguenay sequence variation in a child with ataxia. JAMA Neurol (2013) 0.94

Atypical GLUT1 deficiency with prominent movement disorder responsive to ketogenic diet. Mov Disord (2006) 0.93

Glucose transporter type I deficiency syndrome: epilepsy phenotypes and outcomes. Epilepsia (2012) 0.92

Influence of breastfeeding on cognitive outcomes at age 6-8 years: follow-up of very low birth weight infants. Am J Epidemiol (2003) 0.92

Long-term cognitive benefits of antenatal corticosteroids for prematurely born children with cranial ultrasound abnormalities. Am J Obstet Gynecol (2002) 0.91

Glut1 deficiency syndrome and erythrocyte glucose uptake assay. Ann Neurol (2011) 0.91

Infantile encephaloneuromyopathy and defective mitochondrial translation are due to a homozygous RMND1 mutation. Am J Hum Genet (2012) 0.91

Changes in glucose transport and water permeability resulting from the T310I pathogenic mutation in Glut1 are consistent with two transport channels per monomer. J Biol Chem (2002) 0.91

Neonatal mitochondrial encephaloneuromyopathy due to a defect of mitochondrial protein synthesis. J Neurol Sci (2008) 0.90

Cognitive and adaptive deficits in young children with Duchenne muscular dystrophy (DMD). J Int Neuropsychol Soc (2008) 0.89

Longitudinal changes of mtDNA A3243G mutation load and level of functioning in MELAS. Am J Med Genet A (2009) 0.88

Clinical outcome measures in spinal muscular atrophy. J Child Neurol (2009) 0.88

Murine Glut-1 transporter haploinsufficiency: postnatal deceleration of brain weight and reactive astrocytosis. Neurobiol Dis (2009) 0.87

Resilience in children diagnosed with a chronic neuromuscular disorder. J Dev Behav Pediatr (2011) 0.87

Parental stress in mothers of boys with duchenne muscular dystrophy. J Pediatr Psychol (2003) 0.87

Functional studies of threonine 310 mutations in Glut1: T310I is pathogenic, causing Glut1 deficiency. J Biol Chem (2003) 0.87

Adiposity is increased among high-functioning, non-ambulatory patients with spinal muscular atrophy. Neuromuscul Disord (2010) 0.87

Mitochondrial myopathy and ophthalmoplegia in a sporadic patient with the G12315A mutation in mitochondrial DNA. Neuromuscul Disord (2002) 0.86

Muscle volume estimation by magnetic resonance imaging in spinal muscular atrophy. J Child Neurol (2010) 0.86

Duchenne muscular dystrophy: a cerebellar disorder? Neurosci Biobehav Rev (2007) 0.85

Brain glucose supply and the syndrome of infantile neuroglycopenia. Arch Neurol (2007) 0.84

Mitochondrial disorders. J Child Neurol (2002) 0.83

Autonomic symptoms in carriers of the m.3243A>G mitochondrial DNA mutation. Arch Neurol (2010) 0.83

Classification of infantile seizures: implications for identification and treatment of inborn errors of metabolism. J Child Neurol (2002) 0.83

Glut1 deficiency: inheritance pattern determined by haploinsufficiency. Ann Neurol (2010) 0.82

Reliability of telephone administration of the PedsQL Generic Quality of Life Inventory and Neuromuscular Module in spinal muscular atrophy (SMA). Neuromuscul Disord (2010) 0.82

SMA-MAP: a plasma protein panel for spinal muscular atrophy. PLoS One (2013) 0.82

Effect of the postictal state on visual-spatial memory in immature rats. Epilepsy Res (2003) 0.81

Age at disease onset predicts likelihood and rapidity of growth failure among infants and young children with spinal muscular atrophy types 1 and 2. J Child Neurol (2012) 0.81

Three wishes and psychological functioning in boys with duchenne muscular dystrophy. J Dev Behav Pediatr (2003) 0.80

Decreased hippocampal expression of calbindin D28K and cognitive impairment in MELAS. J Neurol Sci (2012) 0.80

Unusual clinical presentations in four cases of Leigh disease, cytochrome C oxidase deficiency, and SURF1 gene mutations. J Child Neurol (2005) 0.80

Functional studies of the T295M mutation causing Glut1 deficiency: glucose efflux preferentially affected by T295M. Pediatr Res (2008) 0.79

Reversible infantile hypoglycorrhachia: possible transient disturbance in glucose transport? Pediatr Neurol (2003) 0.79

Longitudinal assessment of skill development in children with first febrile seizure. Epilepsy Behav (2013) 0.78

Leg muscle function and fatigue during walking in spinal muscular atrophy type 3. Muscle Nerve (2014) 0.78

Acute hyperglycemia produces transient improvement in glucose transporter type 1 deficiency. Ann Neurol (2010) 0.78

Identification of a novel nemaline myopathy-causing mutation in the troponin T1 (TNNT1) gene: a case outside of the old order Amish. Muscle Nerve (2015) 0.78

Bioelectrical impedance analysis can be a useful screen for excess adiposity in spinal muscular atrophy. J Child Neurol (2010) 0.78

The molecular basis of pyruvate carboxylase deficiency: mosaicism correlates with prolonged survival. Mol Genet Metab (2008) 0.77

Uncovering microdeletions in patients with severe Glut-1 deficiency syndrome using SNP oligonucleotide microarray analysis. Mol Genet Metab (2010) 0.77

Weakness and fatigue in diverse neuromuscular diseases. J Child Neurol (2013) 0.77

T295M-associated Glut1 deficiency syndrome with normal erythrocyte 3-OMG uptake. Brain Dev (2010) 0.76

Fatigue leads to gait changes in spinal muscular atrophy. Muscle Nerve (2011) 0.76

Inherited metabolic disorders and seizures in infancy. J Child Neurol (2002) 0.76

Spinal muscular atrophy type III: trying to understand subtle functional change over time--a case report. J Child Neurol (2011) 0.76

Valproic acid enhances glucose transport in the cultured brain astrocytes of glucose transporter 1 heterozygous mice. J Child Neurol (2012) 0.76

Falls and spinal muscular atrophy: exploring cause and prevention. Muscle Nerve (2012) 0.76